Effect of PPAR‐&bgr;/&dgr; agonist GW0742 treatment in the acute phase response and blood–brain barrier permeability following brain injury

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Translational research : the journal of laboratory and clinical medicine

• Publication date

  2017-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.trsl.2016.10.004PMID 27818230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of PPAR‐&bgr;/&dgr;/miR‐17/TXNIP pathway in neuronal apoptosis after neonatal hypoxic‐ischemic injury in rats

  2018cited by this paper
• Regenerative Rehabilitation: An Innovative and Multifactorial Approach to Recovery From Stroke and Brain Injury.

  2017cited by this paper
• The role of PPAR activation during the systemic response to brain injury

  2015cited by this paper
• Effect of a Broad-Specificity Chemokine-Binding Protein on Brain Leukocyte Infiltration and Infarct Development

  2015cited by this paper
• 12/15-Lipoxygenase metabolites of arachidonic acid activate PPARγ: a possible neuroprotective effect in ischemic brain

  2015cited by this paper
• Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer’s disease through inhibition of inflammation

  2015cited by this paper
• Activation of peroxisome proliferator-activated receptor β/δ attenuates acute ischemic stroke on middle cerebral ischemia occlusion in rats.

  2014influential reference
• Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers

  2014cited by this paper
• CXCR4 Antagonist AMD3100 Protects Blood–Brain Barrier Integrity and Reduces Inflammatory Response After Focal Ischemia in Mice

  2013cited by this paper
• Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant properties.

  2013cited by this paper
• Prevalence of stroke--United States, 2006-2010.

  2012cited by this paper
• Vascular PPARδ Protects Against Stroke-Induced Brain Injury

  2011cited by this paper
• PPARs and their Effects on the Cardiovascular System

  2011cited by this paper
• Vascular PPAR&dgr; Protects Against Stroke-Induced Brain Injury

  2011cited by this paper
• Structure and function of the blood-brain barrier.

  2010cited by this paper
• Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.

  2010cited by this paper
• CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke

  2010cited by this paper
• Neuroprotective effects of leonurine on ischemia/reperfusion-induced mitochondrial dysfunctions in rat cerebral cortex.

  2010cited by this paper
• Effect of Hyperglycemia on Brain Penetrating Arterioles and Cerebral Blood Flow Before and After Ischemia/Reperfusion

  2010cited by this paper
• Leukocyte Recruitment and Ischemic Brain Injury

  2010cited by this paper
• Withdrawal of fenofibrate treatment partially abrogates preventive neuroprotection in stroke via loss of vascular protection.

  2009cited by this paper
• Inflammatory and Neuroimmunomodulatory Changes in Acute Cerebral Ischemia

  2009cited by this paper
• PPARs and the Cardiovascular System

  2009cited by this paper
• Interleukin‐1 exacerbates focal cerebral ischemia and reduces ischemic brain temperature in the rat

  2008cited by this paper
• Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke

  2008cited by this paper
• Prevalence of stroke--United States, 2005.

  2007cited by this paper
• Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor δ-Selective Agonists in Vitro and in Vivo

  2007cited by this paper
• Overexpression of IL-1beta by adenoviral-mediated gene transfer in the rat brain causes a prolonged hepatic chemokine response, axonal injury and the suppression of spontaneous behaviour.

  2007cited by this paper
• Experimental Stroke Induces Massive, Rapid Activation of the Peripheral Immune System

  2006cited by this paper
• Neuroprotection against focal ischemic brain injury by the peroxisome proliferator‐activated receptor‐γ agonist rosiglitazone

  2006cited by this paper
• Inflammation and brain edema: new insights into the role of chemokines and their receptors.

  2006cited by this paper
• Increased Infarct Size and Lack of Hyperphagic Response after Focal Cerebral Ischemia in Peroxisome Proliferator-Activated Receptor β-Deficient Mice

  2006cited by this paper
• Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases.

  2005cited by this paper
• Tumor necrosis factor-alpha-induced apoptosis of human coronary artery endothelial cells: modulation by the peroxisome proliferator-activated receptor-gamma ligand pioglitazone.

  2004cited by this paper
• Post-ischemic inflammation: molecular mechanisms and therapeutic implications

  2004influential reference
• Tumor Necrosis Factor-α-Induced Apoptosis of Human Coronary Artery Endothelial Cells: Modulation by the Peroxisome Proliferator-Activated Receptor-γ Ligand Pioglitazone

  2004cited by this paper
• Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation

  2003cited by this paper
• Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity.

  2003cited by this paper
• CINC‐1 is identified as an acute‐phase protein induced by focal brain injury causing leukocyte mobilization and liver injury

  2003cited by this paper
• Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ)—synthesis and biological activity

  2003cited by this paper
• Altered chemokine expression in the spinal cord and brain contributes to differential interleukin‐1β‐induced neutrophil recruitment

  2002influential reference
• Cerebral ischemia and inflammation

  2001cited by this paper
• Identification and molecular characterization of rat CXCR3: receptor expression and interferon-inducible protein-10 binding are increased in focal stroke.

  2000cited by this paper
• Inflammation and Stroke: Putative Role for Cytokines, Adhesion Molecules and iNOS in Brain Response to Ischemia

  2000cited by this paper
• Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

  2000cited by this paper
• Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats.

  2000cited by this paper
• Contribution of Microglia/Macrophages to Expansion of Infarction and Response of Oligodendrocytes after Focal Cerebral Ischemia in Rats

  2000cited by this paper
• Peroxisome proliferator-activated receptors: nuclear control of metabolism.

  1999cited by this paper

• Lipid droplets in astrocytes: Key organelles for CNS homeostasis and disease (Review)

  2025cites this paper
• Steroid receptor RNA activator enhances hippocampal/amygdaloid PPARδ transcription to counteract anxiety disorders in female mice.

  2025cites this paper
• Elevated CXCL1 triggers dopaminergic neuronal loss in the substantia nigra of C57BL/6J mice: Evaluation of a novel Parkinsonian mouse model

  2025cites this paper
• Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders

  2025cites this paper
• Melatonin Enhanced Microglia M2 Polarization in Rat Model of Neuro-inflammation Via Regulating ER Stress/PPARδ/SIRT1 Signaling Axis

  2024cites this paper
• Highly potent and selective PPARδ agonist reverses memory deficits in mouse models of Alzheimer's disease

  2024cites this paper
• PPAR beta/delta regulates the immune response mechanisms in the porcine endometrium during LPS-induced inflammation - An in vitro study.

  2024cites this paper
• Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets

  2024cites this paper
• PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease.

  2024cites this paper
• Cardarin Effect on the Formation of Histopathological and Behavioral Abnormalities in the Lithium-Pilocarpine Model of Temporal Lobe Epilepsy in Rats

  2024cites this paper
• Electro-acupuncture treatment ameliorates intestinal inflammatory injury in cerebral ischemia-reperfusion rats via regulating the balance of Treg / γδ T cells.

  2023cites this paper
• PPAR agonists for the treatment of neuroinflammatory diseases.

  2023cites this paper
• Progress in the Pathogenesis and Treatment of Neuropsychiatric Systemic Lupus Erythematosus

  2022cites this paper
• Endothelial PPARδ facilitates the post-ischemic vascular repair through interaction with HIF1α

  2022cites this paper
• Experimental study on the role and mechanism of Allicin in ventricular remodeling through PPARα and PPARγ signaling pathways

  2022cites this paper
• Activation of PPAR-β/δ Attenuates Brain Injury by Suppressing Inflammation and Apoptosis in a Collagenase-Induced Intracerebral Hemorrhage Mouse Model

  2020cites this paper
• Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy

  2020cites this paper
• GW0742 activates miR‐17‐5p and inhibits TXNIP/NLRP3‐mediated inflammation after hypoxic‐ischaemic injury in rats and in PC12 cells

  2020cites this paper
• Role of peroxisome proliferator‐activated receptors in stroke prevention and therapy—The best is yet to come?

  2020cites this paper
• Frontline Science: Activation of metabolic nuclear receptors restores periodontal tissue homeostasis in mice with leukocyte adhesion deficiency‐1

  2020cites this paper
• Activation of peroxisome proliferator‐activated receptor delta suppresses BACE1 expression by up‐regulating SOCS1 in a JAK2/STAT1‐dependent manner

  2019cites this paper
• The Medical Management of Cerebral Edema: Past, Present, and Future Therapies

  2019cites this paper
• New progress in the approaches for blood-brain barrier protection in acute ischemic stroke.

  2019cites this paper
• Nervous System Disease in Systemic Lupus Erythematosus: Current Status and Future Directions

  2018cites this paper
• Role of PPAR‐&bgr;/&dgr;/miR‐17/TXNIP pathway in neuronal apoptosis after neonatal hypoxic‐ischemic injury in rats

  2018cites this paper
• Regenerative Rehabilitation: An Innovative and Multifactorial Approach to Recovery From Stroke and Brain Injury.

  2017cites this paper